Study of the type 2 diabetic patients’ status of care and control in rural areas of Ardabil Province in 2017, Iran
Abstract
Introduction. Diabetes mellitus includes a group of metabolic disorders diagnosed by increased serum glucose concentration. It causes major changes in most systems of the body, which lead to acute and chronic complications of the disease which results in disability, medical costs, and high mortality. This research was conducted to assess type 2 diabetic patients’ status of care and control in rural areas of Ardebil province in order to improve the care indicators by presenting results to regional authorities.
Materials and methods. In this cross-sectional descriptive-analytic study, 360 patients identified as type 2 diabetes in rural areas of Ardabil province were selected through cluster sampling and data was collected through a questionnaire by interviewing patients and reviewing their files, and 3 categories of demographic, clinical and socio-economic factors were studied. The data was analyzed by Chi-square and Friedman statistical tests using SPSS software version 20.
Results. According to Chi-square test, there was a significant relationship between the patients’ marital status (p = 0.032) and their complications of diabetes (p = 0.10) and the level of care and between the number of patients’ family members (p = 0.001) and body mass index (p = 0.006) and the level of control and also, between the use of ordered drug by patient and the level of care and control (p = 0.003). The results of the mean ranking based on the Friedman statistical test showed that the age variable has the highest mean score and the greatest impact on the care and control of the disease and the lowest score and impact was of the nutrition education variable.
Conclusion. This study revealed that in order to control the complications of the disease, lifestyle changes, dietary observation, weight control, ordered drug use and self-care programs are very effective.
Keywords: care and controltype 2 diabetesrural areas
References
- Adjah EO, Ray K, Paul S. Ethnicity-specific association of BMI levels at diagnosis of type 2 diabetes with cardiovascular disease and all-cause mortality risk. Acta Diabetologica. 2018; 56(1): 87–96.
- Woodman RJ, Mori TA, Burke V, et al. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr. 2002; 76(5): 1007–1015.
- Dunstan DW, Daly RM, Owen N, et al. High-Intensity Resistance Training Improves Glycemic Control in Older Patients With Type 2 Diabetes. Diabetes Care. 2002; 25(10): 1729–1736.
- Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2015; 161: 69–81.
- Marso SP, Daniels GH, Brown-Frandsen K, et al. LEADER Steering Committee, LEADER Trial Investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016; 375(4): 311–322.
- Levelt E, Pavlides M, Banerjee R, et al. Ectopic and visceral fat deposition in Lean and obese patients with type 2 diabetes. J Am Coll Cardiol. 2016; 68(1): 53–63.
- DeFronzo RA, Ferrannini E, Groop L, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015; 1: 15019.
- Wulffelé MG, Kooy A, de Zeeuw D, et al. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review. J Intern Med. 2004; 256(1): 1–14.
- Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348(5): 383–393.
- Hodgson JM, Watts GF, Playford DA, et al. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr. 2002; 56(11): 1137–1142.
- Colhoun H, Betteridge D, Durrington P, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. The Lancet. 2004; 364(9435): 685–696.
- Scheen A, Finer N, Hollander P, et al. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. The Lancet. 2006; 368(9548): 1660–1672.
- Kemp TM, Barr E, Zimmet PZ, et al. Glucose, Lipid, and Blood Pressure Control in Australian Adults With Type 2 Diabetes: The 1999–2000 AusDiab. Diabetes Care. 2005; 28(6): 1490–1492.
- Fosse-Edorh S, Fagot-Campagna A, Detournay B, et al. Type 2 diabetes prevalence, health status and quality of care among the North African immigrant population living in France. Diabetes Metab. 2014; 40(2): 143–150.
- Zeng B, Sun W, Gary RA, et al. Towards a conceptual model of diabetes self-management among Chinese immigrants in the United States. Int J Environ Res Public Health. 2014; 11(7): 6727–6742.
- Kumar SP, Sandhya AM. A study on the glycemic, lipid and blood pressure control among the type 2 diabetes patients of north Kerala, India. Indian Heart J. 2018; 70(4): 482–485.
- Adjah ESO, Bellary S, Hanif W, et al. Prevalence and incidence of complications at diagnosis of T2DM and during follow-up by BMI and ethnicity: a matched case-control analysis. Cardiovasc Diabetol. 2018; 17(1): 70.